vs

Side-by-side financial comparison of Protagonist Therapeutics, Inc (PTGX) and VERRA MOBILITY Corp (VRRM). Click either name above to swap in a different company.

VERRA MOBILITY Corp is the larger business by last-quarter revenue ($223.6M vs $170.6M, roughly 1.3× Protagonist Therapeutics, Inc). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs 12.0%, a 65.2% gap on every dollar of revenue. On growth, Protagonist Therapeutics, Inc posted the faster year-over-year revenue change (184.4% vs 0.1%). Protagonist Therapeutics, Inc produced more free cash flow last quarter ($182.8M vs $9.6M).

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.

Verra Mobility Corp is a leading global smart mobility technology solution provider. It delivers toll management, parking and traffic compliance enforcement, connected vehicle services, and fleet management tools, serving government transport agencies, rental car operators, commercial fleet owners, and automotive partners across North America, Europe, and Asia-Pacific.

PTGX vs VRRM — Head-to-Head

Bigger by revenue
VRRM
VRRM
1.3× larger
VRRM
$223.6M
$170.6M
PTGX
Growing faster (revenue YoY)
PTGX
PTGX
+184.3% gap
PTGX
184.4%
0.1%
VRRM
Higher net margin
PTGX
PTGX
65.2% more per $
PTGX
77.2%
12.0%
VRRM
More free cash flow
PTGX
PTGX
$173.2M more FCF
PTGX
$182.8M
$9.6M
VRRM

Income Statement — Q4 FY2024 vs Q1 FY2026

Metric
PTGX
PTGX
VRRM
VRRM
Revenue
$170.6M
$223.6M
Net Profit
$131.7M
$26.7M
Gross Margin
Operating Margin
74.3%
23.2%
Net Margin
77.2%
12.0%
Revenue YoY
184.4%
0.1%
Net Profit YoY
381.7%
-17.3%
EPS (diluted)
$2.01
$0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTGX
PTGX
VRRM
VRRM
Q1 26
$223.6M
Q4 25
$257.9M
Q3 25
$261.9M
Q2 25
$236.0M
Q1 25
$223.3M
Q4 24
$170.6M
$221.5M
Q3 24
$225.6M
Q2 24
$222.4M
Net Profit
PTGX
PTGX
VRRM
VRRM
Q1 26
$26.7M
Q4 25
$18.9M
Q3 25
$46.8M
Q2 25
$38.6M
Q1 25
$32.3M
Q4 24
$131.7M
$-66.7M
Q3 24
$34.7M
Q2 24
$34.2M
Operating Margin
PTGX
PTGX
VRRM
VRRM
Q1 26
23.2%
Q4 25
16.7%
Q3 25
28.6%
Q2 25
26.8%
Q1 25
25.7%
Q4 24
74.3%
-19.6%
Q3 24
28.3%
Q2 24
27.5%
Net Margin
PTGX
PTGX
VRRM
VRRM
Q1 26
12.0%
Q4 25
7.3%
Q3 25
17.9%
Q2 25
16.3%
Q1 25
14.5%
Q4 24
77.2%
-30.1%
Q3 24
15.4%
Q2 24
15.4%
EPS (diluted)
PTGX
PTGX
VRRM
VRRM
Q1 26
$0.17
Q4 25
$0.12
Q3 25
$0.29
Q2 25
$0.24
Q1 25
$0.20
Q4 24
$2.01
$-0.39
Q3 24
$0.21
Q2 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTGX
PTGX
VRRM
VRRM
Cash + ST InvestmentsLiquidity on hand
$418.9M
$46.9M
Total DebtLower is stronger
$34.1M
Stockholders' EquityBook value
$675.3M
$272.0M
Total Assets
$744.7M
$1.7B
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTGX
PTGX
VRRM
VRRM
Q1 26
$46.9M
Q4 25
$65.3M
Q3 25
$196.1M
Q2 25
$147.7M
Q1 25
$108.5M
Q4 24
$418.9M
$77.6M
Q3 24
$206.1M
Q2 24
$122.0M
Total Debt
PTGX
PTGX
VRRM
VRRM
Q1 26
$34.1M
Q4 25
$1.0B
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Stockholders' Equity
PTGX
PTGX
VRRM
VRRM
Q1 26
$272.0M
Q4 25
$293.0M
Q3 25
$403.1M
Q2 25
$352.1M
Q1 25
$299.6M
Q4 24
$675.3M
$265.1M
Q3 24
$486.5M
Q2 24
$438.6M
Total Assets
PTGX
PTGX
VRRM
VRRM
Q1 26
$1.7B
Q4 25
$1.6B
Q3 25
$1.8B
Q2 25
$1.7B
Q1 25
$1.6B
Q4 24
$744.7M
$1.6B
Q3 24
$1.9B
Q2 24
$1.8B
Debt / Equity
PTGX
PTGX
VRRM
VRRM
Q1 26
0.13×
Q4 25
3.51×
Q3 25
2.55×
Q2 25
2.93×
Q1 25
3.45×
Q4 24
3.90×
Q3 24
2.13×
Q2 24
2.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTGX
PTGX
VRRM
VRRM
Operating Cash FlowLast quarter
$184.2M
$40.8M
Free Cash FlowOCF − Capex
$182.8M
$9.6M
FCF MarginFCF / Revenue
107.1%
4.3%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
1.40×
1.53×
TTM Free Cash FlowTrailing 4 quarters
$101.7M
$104.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTGX
PTGX
VRRM
VRRM
Q1 26
$40.8M
Q4 25
$40.0M
Q3 25
$77.7M
Q2 25
$75.1M
Q1 25
$63.0M
Q4 24
$184.2M
$40.5M
Q3 24
$108.8M
Q2 24
$40.0M
Free Cash Flow
PTGX
PTGX
VRRM
VRRM
Q1 26
$9.6M
Q4 25
$5.7M
Q3 25
$49.0M
Q2 25
$40.3M
Q1 25
$41.7M
Q4 24
$182.8M
$21.6M
Q3 24
$85.1M
Q2 24
$26.0M
FCF Margin
PTGX
PTGX
VRRM
VRRM
Q1 26
4.3%
Q4 25
2.2%
Q3 25
18.7%
Q2 25
17.1%
Q1 25
18.7%
Q4 24
107.1%
9.8%
Q3 24
37.7%
Q2 24
11.7%
Capex Intensity
PTGX
PTGX
VRRM
VRRM
Q1 26
Q4 25
13.3%
Q3 25
11.0%
Q2 25
14.8%
Q1 25
9.5%
Q4 24
0.8%
8.5%
Q3 24
10.5%
Q2 24
6.3%
Cash Conversion
PTGX
PTGX
VRRM
VRRM
Q1 26
1.53×
Q4 25
2.12×
Q3 25
1.66×
Q2 25
1.95×
Q1 25
1.95×
Q4 24
1.40×
Q3 24
3.13×
Q2 24
1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTGX
PTGX

Segment breakdown not available.

VRRM
VRRM

Government Solutions segment generated total$105.3M47%
Commercial Services segment generated total$97.8M44%
Parking Solutions segment generated total$20.4M9%

Related Comparisons